IDiyas

For the Inventor, By the Inventor

Londonderry, NH, United States of America

Charles E Chase

USPTO Granted Patents = 30 


 

Average Co-Inventor Count = 3.7

ph-index = 15

Forward Citations = 682(Granted Patents)


Company Filing History:

goldMedal30 out of 527 
 
Eisai R&d Management Co., Ltd.
 patents

Years Active: 2010-2023

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 11643418 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B (2023-05-09),
2. 11136335 - Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof (2021-10-05),
3. 10934307 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B (2021-03-02),
4. 10913749 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides (2021-02-09),
5. 10717743 - Intermediates and methods for the synthesis of halichondrin B analogs (2020-07-21),
6. 10676481 - Intermediates in the synthesis of eribulin and related methods of synthesis (2020-06-09),
7. 10611773 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B (2020-04-07),
8. RE47797 - Intermediates for the preparation of analogs of halichondrin B (2020-01-06),
9. 10494388 - Compounds useful in the synthesis of halichondrin B analogs (2019-12-03),
10. 10308661 - Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides (2019-06-04),
11. 10221189 - Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B (2019-03-05),
12. 10214539 - Intermediates and methods for the synthesis of halichondrin B analogs (2019-02-26),
13. RE46965 - Intermediates for the preparation of analogs of Halichondrin B (2018-07-23),
14. 9856276 - Compounds useful in the synthesis of halichondrin B analogs (2018-01-02),
15. 9802953 - Intermediates and methods for the synthesis of halichondrin B analogs (2017-10-31),

Title: The Innovations of Charles E Chase in Pharmaceutical Synthesis

Introduction: Charles E Chase, a prolific inventor hailing from Londonderry, NH, has made significant contributions to the field of pharmaceutical synthesis. With an impressive portfolio of 30 patents, his groundbreaking research has paved the way for the development of novel drug compounds.

Latest Patents: Among his latest patents are innovative methods for the synthesis of eribulin and halichondrin macrolides. One patent focuses on macrocyclization reactions, offering a strategic approach to the synthesis of eribulin and its salts. The other patent explores the use of Prins reaction for the synthesis of halichondrin macrolides and analogs, showcasing his expertise in diverse synthetic methodologies.

Career Highlights: Charles Chase is a distinguished member of Eisai R&D Management Co., Ltd., a renowned pharmaceutical research and development company. His tenure at Eisai has been marked by a series of groundbreaking inventions that have advanced the field of drug discovery and development.

Collaborations: Throughout his career, Charles has collaborated closely with esteemed colleagues such as Francis Gerard Fang and Atsushi Endo. Together, they have synergized their expertise to pioneer new synthetic pathways and optimize the production of complex pharmaceutical compounds.

Conclusion: In conclusion, Charles E Chase stands as a trailblazer in the realm of pharmaceutical synthesis, with a remarkable track record of innovative patents that have reshaped the landscape of drug development. His unwavering commitment to scientific excellence continues to inspire future generations of inventors in the pursuit of groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…